Q. Were 1990-1991 Gulf War veterans exposed to biological agents?
A. We have no evidence that biological weapons were
used during the 1990-1991 Gulf War. In addition we have not found any reports of
verified biological agent detections nor are we aware of anyone, soldier
or civilian, who has reported experiencing symptoms consistent with exposure
to a biological agent.
To date, there is also no evidence that any warfareagents
were released as a result of coalition bombings during the air war campaign,
January 17, 1991 through February 23, 1991
Q. What were the U.S. capabilities for detecting biological
A. During the 1990-1991 Gulf War we deployed 17 research and
development systems to the Gulf region to monitor the air for suspected
Iraqi biological warfare (BW) agents. Twelve of the 17 systems were mobile,
and consisted of the Army's XM-2 high volume air samplers and Sensitive
Membrane Antigen Rapid Test (SMART) identification tickets. The mobile
systems moved across northeast Saudi Arabia to monitor for Iraqi BW agent
attacks. The remaining five systems were employed in a static mode at
critical logistics facilities and consisted of a modified commercial aerosol
sampler with SMART tickets. The mobile units were mounted on HUMVEES and
on Isuzu Troopers. These XM-2 air samplers had inherent limitations. They
were too big and heavy, had low reliability and an unacceptable false
alarm rate. Units that deployed with these systems included personnel
from the Edgewood Research Development Engineering Center in mid-Jan 91
and elements of the 9th CM Co, an active component unit from Fort Lewis
arrived a few weeks later. This unit was deactivated in Feb 94.
Detections from these systems included the following:
Two thousand anthrax and botulinum SMART tickets were used
during the 1990-1991 Gulf War. Less than 1% of these gave a positive reading at
the respective sampling points. Confirmatory tests of the samples at the
Navy's Forward Deployed Medical Diagnostic Lab indicated that all samples
were free of suspected BW agent.
Since the 1990-1991 Gulf War we have pursued an aggressive program
to field a robust detection system that will protect our forces against
a wide spectrum of BW threats. We have fielded two new systems and are
developing a third.
In December 1996, the Joint Program Office for Biological
Defense (JPO-BD) awarded a contract for the engineering and manufacturing
development of the Joint Biological Point Detection System (JBPDS); the
next generation system with an enhanced, common biological detection suite
that will be employed on all four services' platforms (i.e., Army and
Marine Corps HUMVEESs, Navy ships and AF bases).
In June 1995 the Army had one platoon of the 11th Chemical
Company at Fort McClellan, Alabama, equipped with the Biological Integrated
Detection System (BIDS). On 16 September 1996, the Army activated its
first biological detection company, the 310th Chemical Company (Reserve
Component) at Fort McClellan. This company is equipped with 38 HMMWV-mounted
BIDS and three Long Range Biological Standoff Detection Systems (LR-BSDS).
These are enough systems to provide Corps-size coverage.
In September 1994 we fielded the Navy's Interim Biological
Agent Detector (IBAD) aboard the USS LaSalle. Nine more IBADS have been
deployed with the fleet since then. The Navy will have a total of 25 systems
deployed by the end of September 1997.
Biological Point Detection Systems
Nuclear, Biological, and Chemical (NBC) Detection site
no longer available
Committee Interim Report
Return to FAQs